Massachusetts-based biotechnology company HotSpot Therapeutics has partnered with global data and analytics company Excelra to leverage the latter’s Global Online Structure Activity Relationship Database (GOSTAR) platform to identify new drug targets. The terms and financial details of the partnership have not been disclosed.
The partnership will integrate GOSTAR’s comprehensive datasets, which include over eight million molecules and binding data, with Hotspot’s AI/ML models to accelerate the discovery of novel allosteric targets and therapeutics.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.